American ENT surgeon, Professor John Oghalai has received funding for a groundbreaking research project to use equipment normally used in...
Read moreDetailsWorld first regenerative cell therapy to replace damaged sensory cells in the inner ear, aiming to restore hearing, is expected...
Read moreDetailsA captioned telephone technology service is offering free infographics on four types of hearing loss for hearing practitioners to give...
Read moreDetailsPeople with sudden hearing loss who receive steroids within seven days are five times more likely to fully recover their...
Read moreDetailsA German otorhinolaryngology research team has developed drug-eluting implants it hopes will be able to treat idiopathic sudden sensorineural hearing...
Read moreDetailsMedChem Australia will support an Ear Science Institute Australia project researching novel small molecules for the treatment of sensorineural hearing...
Read moreDetailsMicrotia Atresia Australia is running three conferences nationwide this year to help families make informed decisions for their school-aged children...
Read moreDetailsAn American biotechnology company will trial giving its new investigational drug to cochlear implant recipients to see if it reduces...
Read moreDetailsPioneering gene therapy has restored hearing in a British baby born with profound genetic deafness, along with other children in...
Read moreDetailsSeven hearing-related projects and services that benefit children will receive funds from Western Australia’s Telethon appeal in 2024. They range...
Read moreDetailsHearing Practitioner Australia is the only independent business-to-business publication for the nation’s hearing industry. The multi-channel platform has been established out of the need for premium, local and independent content relevant to today’s audiologists, audiometrists, otolaryngologists/ENTs and other hearing professionals in Australia.
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited